Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | THPO | P40225 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CETP | P11597 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | UBE2N | P61088 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30729227 | 0.97 | LMNA (0.52) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL28816539 | 0.97 | LMNA (0.52) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL3364419 | 0.97 | LMNA (0.58) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL6159762 | 0.97 | LMNA (0.58) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL6157389 | 0.97 | LMNA (0.58) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL1019405 | 0.97 | LMNA (0.58) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL3370075 | 0.97 | LMNA (0.58) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL19154283 | 0.97 | LMNA (0.58) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL1660059 | 0.97 | LMNA (0.58) | LMNAOPRM1CYP2D6SPHK1TP53 | |
| SCHEMBL14878243 | 0.97 | LMNA (0.58) | LMNAOPRM1CYP2D6SPHK1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116601158-A | Modulators of cystic fibrosis transmembrane conductance regulator | 弗特克斯药品有限公司 | 2023-08-15 | — | — | CN | disclosed |
| US-20160201093-A1 | Process for the Bioconversion of C3-C13 Alkanes to C3-C13 Primary Alcohols | BASF SE (DE) | 2016-07-14 | — | — | US | disclosed |
| EP-3027760-A1 | PROCESS FOR THE BIOCONVERSION OF C3-C13 ALKANES TO C3-C 13 PRIMARY ALCOHOLS | BASF SE (DE) | 2016-06-08 | — | — | EP | disclosed |
| WO-2015014644-A1 | PROCESS FOR THE BIOCONVERSION OF C3-C13 ALKANES TO C3-C 13 PRIMARY ALCOHOLS | BASF SE (DE) | 2015-02-05 | — | — | WO | disclosed |
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20130131169-A1 | COOLING SENSATION AGENT COMPOSITION, SENSORY STIMULATION AGENT COMPOSITION AND USE OF THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-05-23 | — | — | US | disclosed |
| US-8377458-B2 | Cooling sensation agent composition, sensory stimulation agent composition and use of the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8263972-B2 | Organic electroluminescent device and display medium | FUJI XEROX CO. LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8217391-B2 | Organic semiconductor transistor, method of producing the same, and electronic device | FUJI XEROX CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| EP-1730142-B1 | NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS | SCHERING CORP (US) | 2011-06-29 | — | — | EP | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| US-20110081393-A1 | COOLING SENSATION AGENT COMPOSITION, SENSORY STIMULATION AGENT COMPOSITION AND USE OF THE SAME | TAKASAGO INTERNATIONAL CORPORATION | 2011-04-07 | — | — | US | disclosed |
| EP-2233488-B1 | THIAZOLOTHIAZOLE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | FUJI XEROX CO LTD (JP) | 2011-01-12 | — | — | EP | disclosed |
| US-20100276672-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY MEDIUM | FUJI XEROX CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| US-7812172-B2 | Charge transport materials; for organic electronic devices such as organic photoreceptors, organic electroluminescence devices, organic transistors, and organic optical memories | FUJI XEROX CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100243995-A1 | ORGANIC SEMICONDUCTOR TRANSISTOR, METHOD OF PRODUCING THE SAME, AND ELECTRONIC DEVICE | FUJI XEROX CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| EP-2233488-A1 | THIAZOLOTHIAZOLE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | Fuji Xerox Co., Ltd. (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20100137611-A1 | THIAZOLOTHIAZOLE DERIVATIVE | FUJI XEROX CO., LTD. (JP) | 2010-06-03 | — | — | US | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
| US-6696395-B1 | CLEANING COMPOUNDS COMPRISING ODORS, WATER AND SURFACTANTS IN HIGH DENSITY POLYOLEFIN CONTAINERS HAVING INTERIOR LININGS SELECTED FROM NYLON, POLYETHYLENE TEREPHTHALATE OR FLUORINATED POLYETHYLENE FOR STORAGE STABILITY; NONDIFFUSING BARRIERS | THE PROCTER & GAMBLE COMPANY | 2004-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100276672-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY MEDIUM | L1CAM, OR10J3, ALK | LMNA 2011/4885OPRM1 129/4885CYP2D6 827/4885 |
| US-20100137611-A1 | THIAZOLOTHIAZOLE DERIVATIVE | BCAT1, ABAT, BCAT2 | LMNA 3875/4885OPRM1 2423/4885CYP2D6 561/4885 |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | LMNA 1708/4885OPRM1 69/4885CYP2D6 2862/4885 |
| US-20110081393-A1 | COOLING SENSATION AGENT COMPOSITION, SENSORY STIMULATION AGENT COMPOSITION AND USE OF THE SAME | TRPA1, TRPV1, TRPM4 | LMNA 1727/4885OPRM1 493/4885CYP2D6 2821/4885 |
| US-20130131169-A1 | COOLING SENSATION AGENT COMPOSITION, SENSORY STIMULATION AGENT COMPOSITION AND USE OF THE SAME | TRPA1, TRPV1, TRPM4 | LMNA 1727/4885OPRM1 493/4885CYP2D6 2821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.